NASDAQ · Biotechnology

Aktis Oncology, Inc. (AKTS) Stock

$18.15 +2.31% NASDAQ: AKTS Healthcare

Valuation

MetricValue
Price$18.15
Market Cap$969.29M
P/E Ratio-17.01
P/B Ratio2.04
P/S Ratio94.81
EPS (TTM)$-1.81
52-Week High$34.19
52-Week Low$14.72
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-41.07%
ROA-13.12%
ROCE-16.59%
Gross Margin81.95%
Operating Margin-813.35%
Net Margin-727.04%
Debt/Equity0.02
Current Ratio16.33

Annual Financials (USD)

Metric2022202320242025
Revenue$0$0$1.0M$6.0M
Operating Profit$-20.0M$-35.0M$-52.0M$-75.0M
Net Profit$-18.0M$-29.0M$-44.0M$-64.0M
EPS$-0.51$-0.82$-1.26$-1.19
Op Margin——-3500.3%-1149.5%

Balance Sheet (USD)

Metric2022202320242025
Total Assets$138.0M$122.0M$326.0M$265.0M
Total Liabilities$158.0M$169.0M$414.0M$411.0M
Cash$129.0M$30.0M$37.0M$38.0M
Borrowings$2.0M$13.0M$12.0M$12.0M

Latest News

Aktis Oncology Insider Sold Shares Worth $1,387,558, According to a Recent SEC Filing MT Newswires · Jul 10, 2026 Aktis Oncology Insider Sold Shares Worth $1,388,701, According to a Recent SEC Filing MT Newswires · Jul 10, 2026 Raymond James Initiates Aktis Oncology at Strong Buy With $40 Price Target MT Newswires · Jun 16, 2026 Aktis Oncology to Present at the Jefferies Global Healthcare Conference GlobeNewswire · May 27, 2026 A Look At Aktis Oncology (AKTS) Valuation After Recent Share Price Rebound Simply Wall St. · May 25, 2026

Cash Flow (USD)

Metric2022202320242025
Operating Cash Flow$-18.0M$-30.0M$15.0M$-64.0M
Investing Cash Flow$-5.0M$-73.0M$-193.0M$56.0M
Financing Cash Flow$0$0$-2.0M$-2.0M
Net Cash Flow$100.0M$-99.0M$8.0M$1.0M
Free Cash Flow$-20.0M$-34.0M$12.0M$-74.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.16
EV / EBITDA-11.35
FCF Yield-8.87%
Quick Ratio16.33
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held14.14%
Institutions Held74.41%
Institutions Float Held86.67%
Institutional HolderSharesReport Date
MPM Bioimpact LLC4,835,8722026-03-31
EcoR1 Capital, LLC4,824,4692026-03-31
Blue Owl Capital Holdings LP3,161,3482026-03-31
Wellington Management Group, LLP2,317,0442026-03-31
T. Rowe Price Investment Management, Inc.2,123,8122026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AKTXAkari Therapeutics, Plc $8.43 -0.35% -0.01 $9.65M 0.00%
AURAAura Biosciences, Inc. $6.54 +0.54% -3.42 $676.47M 0.00%
BCYCBicycle Therapeutics plc $4.22 +0.24% -1.34 $292.84M 0.00%
IMCRImmunocore Holdings plc $31.95 -3.42% -85.34 $1.62B 0.00%
IMNMImmunome, Inc. $19.55 +1.24% -8.23 $1.87B 0.00%

About Aktis Oncology, Inc.

Aktis Oncology, Inc. is led by CEO Matthew Roden, employs 79 people, headquartered in US, publicly traded since 2026.

Aktis Oncology, Inc. (AKTS) stock trades at $18.15 with a market capitalization of $969.29M. The stock is valued at a price-to-earnings (P/E) ratio of -17.01, price-to-book of 2.04, price-to-sales of 94.81. Over the past 52 weeks the stock has ranged between $14.72 and $34.19, and currently trades 46.9% below its 52-week high.

On profitability, Aktis Oncology, Inc. generates a return on equity (ROE) of -41.07%, return on capital employed of -16.59%, an operating margin of -813.35%, a net profit margin of -727.04%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides